V

Verona Pharma plc
D

VRNA

68.020
USD
3.85
(6.00%)
مغلق
حجم التداول
80,990
الربح لكل سهم
0
العائد الربحي
-
P/E
-34
حجم السوق
5,566,156,183
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
الأخبار
المقالات

العنوان: Verona Pharma plc

القطاع: Healthcare
الصناعة: Biotechnology
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.